about
Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stabilityEnhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunctionEndoplasmic Reticulum Stress and Microvascular Endothelial Dysfunction in Diabetes.Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species.The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice.Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic miceNOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stressEnhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice.Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitorsMercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways.Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics.Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli.Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activityLa presencia de obesidad infantil puede enmascarar el diagnóstico de diabetes monogénicaLysyl oxidase (LOX) in vascular remodellingT-regulatory cells and vascular function: the importance of their immunosuppressive action in hypertensive diseasePathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targetsEmerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic ChallengesNeuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophyEnhanced endoplasmic reticulum and mitochondrial stress in abdominal aortic aneurysm
P50
Q24324773-757814BD-9078-4913-A48E-4B6512B8029FQ30540016-E8A936BB-B82E-4530-B5D4-A083C679499CQ33861097-025160D1-4197-4B52-8D5F-ED4434EBE6A0Q34479206-3467E7CB-A535-4333-9323-AED6813C2130Q34699484-FABFF702-D78D-45DE-81D6-34381809E25AQ34837862-5A4F39FA-FE02-402E-BF6D-9038727AEDFCQ35687138-831C4EAF-96E9-4909-8AC8-2214DADDBBE1Q35903412-B73B9FE3-90F5-48A1-8837-8EF51C567810Q35917666-148D6A63-5AD8-4D02-B8F7-4DC90DADE7C2Q36791018-2790A02E-77BC-452F-8BCC-A320C7CB17D4Q37274168-BE6C4FA1-73CC-4150-BFD8-73F3517C037AQ37656092-4066B4FC-AB6D-4C3A-AD30-4A5998180F9EQ37731473-C97F63AD-365B-437C-B00A-C59A03CE1FA9Q39910687-F49F283E-B9E2-492C-8FE2-97B4DAD0C7ACQ42712909-55189469-A99E-49BA-80AD-5271CE166DE4Q46363802-C26FDF05-6411-43D0-81F1-34AF1D0D1ABDQ46609201-51979FD8-D780-4328-A9CC-17C2CBEA73BBQ53119799-9B9C7947-705A-45DE-8410-48928DEA6D3FQ54625746-5580BA4D-CB2D-4A6F-A9F4-FE5FB18BF159Q58763545-06DA0A7B-8258-4BFB-95EF-CDD552A9B5CBQ60708820-B6828DFB-D4D8-4B96-A822-1685B99B89AFQ61864787-C80EECD0-A159-4903-8C04-0B4002EF4930Q86844968-637C891E-6CCD-4A8C-92CD-C6A249A7D682Q90351392-BAFC9697-4093-400D-B2C0-72433CBFED67Q90725298-D69FD47A-7DBE-42FA-97C4-087ABB71C871Q92959980-6E2483C1-6384-4210-B19F-2FB7FD91B8EBQ93023000-D340D088-2AE9-482E-BDA2-893357F8D9B2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
María Galán
@ast
María Galán
@en
María Galán
@es
María Galán
@nl
type
label
María Galán
@ast
María Galán
@en
María Galán
@es
María Galán
@nl
prefLabel
María Galán
@ast
María Galán
@en
María Galán
@es
María Galán
@nl
P108
P106
P108
P31
P496
0000-0002-4758-8388